The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

New research supports brain cell transplantation as a treatment for some neurological disorders. A team from McGill ...

The Iowa Chapter of the American Parkinson Disease Association is holding a Parkinson education program from 1 to 3:30 p.m. Wednesday at the Fort Dodge Public Library, 424 Central Ave. The event is ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Topline results from the Phase 2a trial of VTX3232 in patients with early Parkinson’s disease expected in H1 2025 Phase 2 ... as a best-in-class CNS-penetrant NLRP3 inhibitor for the treatment of ...

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not diagnosed until ...

paving the way for spotting and treating neurodegenerative diseases like multiple sclerosis and Parkinson's disease at earlier stages. The answer to this is not as simple as you might think. New ...